Journal of Clinical Medicine (May 2021)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies

  • Marjorie Canu,
  • Léa Margerit,
  • Ismail Mekhdoul,
  • Alexis Broisat,
  • Laurent Riou,
  • Loïc Djaileb,
  • Clémence Charlon,
  • Adrien Jankowski,
  • Michele Magnesa,
  • Caroline Augier,
  • Stéphanie Marlière,
  • Muriel Salvat,
  • Charlotte Casset,
  • Marion Maurin,
  • Carole Saunier,
  • Daniel Fagret,
  • Catherine Ghezzi,
  • Gerald Vanzetto,
  • Gilles Barone-Rochette

DOI
https://doi.org/10.3390/jcm10102183
Journal volume & issue
Vol. 10, no. 10
p. 2183

Abstract

Read online

Background: Atherosclerosis is associated with a worse prognosis in many diseases such as ischemic cardiomyopathy, but its impact in non-ischemic dilated cardiomyopathy (dCMP) is lesser known. Our aim was to study the prognostic impact of coronary atherosclerotic burden (CAB) in patients with dCMP. Methods: Consecutive patients with dCMP and left ventricular (LV) dysfunction diagnosed by concomitant analysis of invasive coronary angiography (ICA) and CMR imaging were identified from registry-database. CAB was measured by Gensini score. The primary composite endpoint was the occurrence of major adverse cardiovascular events (MACE) defined as cardiovascular (CV) mortality, non-fatal MI and unplanned myocardial revascularization. The results of 139 patients constituting the prospective study population (mean age 59.4 ± 14.7 years old, 74% male), average LV ejection fraction was 31.1 ± 11.02%, median Gensini score was 0 (0–3), and mid-wall late gadolinium enhancement (LGE) was the most frequent LGE pattern (42%). Over a median follow-up of 2.8 years, 9% of patients presented MACE. Patients with MACE had significantly higher CAB compared to those who were free of events (0 (0–3) vs. 3.75 (2–15), p p = 0.02). Conclusion: High CAB may be a new prognostic factor in dCMP patients.

Keywords